Scientist, Upstream – mRNA Drug Substance
Scientist, Upstream – mRNA Drug Substance
04/04/23
Location
Belgium
Vacancy
The Cell and Viral Drug Substance team within the GSK Vaccine’s Technical Research and Development organization, has as a mission to develop the next generation mRNA vaccine platforms for rapid development of new vaccine candidates.
We are looking for a motivated scientist with a strong background in nucleic acid to research join the mRNA drug substance Development Unit and be part of the integration of an external partner Drug Substance platform process for clinical & commercial manufacturing of mRNA. Located in Rixensart, Belgium, the position will play a significant role in shaping current and next generation GSK’s leading mRNA vaccine platforms to accelerate addressing unmet medical needs, an exciting field having a direct impact into patients and global health. This role provides the opportunity to integrate a diverse group of top talented experts in vaccines’ industry, lead key activities and further grow and progress in your career.
Your responsibilities:
Internalization of a pre-established upstream mRNA vaccine platform from an external partner and mature its robustness, scalability, and characterization for late phase CMC development and commercial manufacturing
Key contributor to designing, driving and executing hands on the generation of stage-appropriate data and documentation packages for regulatory submissions using QbD principles (Technical risk assessments, process characterization, etc)
Hands on development work as required according to platform evolution
Contribute to building the mRNA platform documentation and workflows, and integration within the upstream, analytical and other transversal teams within the global platform
Why you?
Basic Qualifications:
We are looking for professionals with these required skills to achieve our goals:
PhD in bio-engineering, biochemistry, biotechnology, chemistry or equivalent or a Master in bio-engineering, biochemistry, biotechnology, chemistry or equivalent.
A minimum of 3-5 years’ experience in gene therapies or specifically mRNA-based vaccines or therapeutics.
Two or more years of experience in research and development in Biopharmaceutical industry or government laboratory setting is a must.
Excel at complex problem solving through critical thinking using knowledge gained through formal education, experience, and sound judgment.
Preferred Qualifications:
If you have the following characteristics, it would be a plus:
Experience with Quality by Design and development of process for manufacturing of large biomolecules, specifically large size mRNA.
Experience with large-scale DNA and RNA synthesis.
Experience and understanding of nucleic acid analytical technologies.